Approaches to improve angiogenesis in tissue‐engineered skin

A problem with tissue‐engineered skin is clinical failure due to delays in vascularization. The aim of this study was to explore a number of simple strategies to improve angiogenesis/vascularization using a tissue‐engineered model of skin to which small vessel human dermal microvascular endothelial cells were added. For the majority of these studies, a modified Guirguis chamber was used, which allowed the investigation of several variables within the same experiment using the same human dermis; cell type, angiogenic growth factors, the influence of keratinocytes and fibroblasts, mechanical penetration of the human dermis, the site of endothelial cell addition, and the influence of hypoxia were all examined. A qualitative scoring system was used to assess the impact of these factors on the penetration of endothelial cells throughout the dermis. Similar results were achieved using freshly isolated small vessel human dermal microvascular endothelial cells or an endothelial cell line and a minimum cell seeding density was identified. Cell penetration was not influenced by the addition of angiogenic growth factors (vascular endothelial growth factor and basic fibroblast growth factor); similarly, including epidermal keratinocytes or dermal fibroblasts did not encourage endothelial cell entry, and neither did mechanical introduction of holes throughout the dermis. Two factors were identified that significantly enhanced endothelial cell penetration into the dermis: hypoxia and the site of endothelial cell addition. Endothelial cells added from the papillary surface entered into the dermis much more effectively than when cells were added to the reticular surface of the dermis. We conclude that this model is valuable in improving our understanding of how to enhance vascularization of tissue‐engineered grafts.

[1]  D. Schmitt,et al.  IL‐4 and interferon‐γ differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts , 2002, Experimental dermatology.

[2]  H. Green,et al.  Seria cultivation of strains of human epidemal keratinocytes: the formation keratinizin colonies from single cell is , 1975, Cell.

[3]  S. Macneil,et al.  Keratinocytes contract human dermal extracellular matrix and reduce soluble fibronectin production by fibroblasts in a skin composite model. , 1997, British journal of plastic surgery.

[4]  Kiichi Hirota,et al.  Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 , 2003, Circulation research.

[5]  R. Swerlick,et al.  HMEC-1: establishment of an immortalized human microvascular endothelial cell line. , 1992, The Journal of investigative dermatology.

[6]  M. M. Ghosh,et al.  A Comparison of Methodologies for the Preparation of Human Epidermal‐Dermal Composites , 1997, Annals of plastic surgery.

[7]  Nicola J Brown,et al.  Development of a reconstructed human skin model for angiogenesis , 2003, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[8]  H. Granger,et al.  Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. , 1988, The American journal of physiology.

[9]  D. Connolly,et al.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. , 1989, The Journal of clinical investigation.

[10]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[11]  Lucie Germain,et al.  In vitro reconstruction of a human capillary‐like network in a tissue‐engineered skin equivalent , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  K. Wagner,et al.  Tie2 Receptor Expression Is Stimulated by Hypoxia and Proinflammatory Cytokines in Human Endothelial Cells , 2000, Circulation research.

[13]  S. Mac Neil,et al.  Development of autologous human dermal–epidermal composites based on sterilized human allodermis for clinical use , 1999, The British journal of dermatology.

[14]  P. Huguet,et al.  Burned breast reconstructive surgery with Integra dermal regeneration template. , 2003, British journal of plastic surgery.

[15]  K. Scharffetter-Kochanek,et al.  Essential role of an activator protein-2 (AP-2)/specificity protein 1 (Sp1) cluster in the UVB-mediated induction of the human vascular endothelial growth factor in HaCaT keratinocytes. , 2003, The Biochemical journal.

[16]  P. McGuire,et al.  Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition , 2003, Progress in Retinal and Eye Research.

[17]  M. Detmar,et al.  Angiogenesis promoted by vascular endothelial growth factor: regulation through alpha1beta1 and alpha2beta1 integrins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Dvorak,et al.  Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. , 1997, The Journal of investigative dermatology.

[19]  J. Sandy,et al.  Psychological outcomes amongst cleft patients and their families. , 1997, British journal of plastic surgery.

[20]  H. Dvorak,et al.  Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. , 1995, The Journal of investigative dermatology.